Zyllexa Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.24 M
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Revenue Growth 161.56%
- Profit Growth -1255.33%
- Ebitda -110.15%
- Net Worth -29.15%
- Total Assets 65.06%
About Zyllexa Formulations
Zyllexa Formulations Private Limited (ZFPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 June 2014 and has a history of Ten years and eight months. Its registered office is in Kozhikode, Kerala, India.
The Corporate was formerly known as Zyllexa Pharmaceuticals Private Limited. The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.24 M.
The company currently has active open charges totaling ₹1.00 M.
Nellikkathodi Bimelsha and Tarun Kodasseri serve as directors at the Company.
Company Details
-
Location
Kozhikode, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397KL2014PTC036688
-
Company No.
036688
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jun 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Zyllexa Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nellikkathodi Bimelsha
|
Director | 13-Sep-2021 | Current |
|
Tarun Kodasseri
|
Director | 16-Oct-2018 | Current |
Financial Performance of Zyllexa Formulations.
Zyllexa Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 161.56% increase. The company also saw a substantial fall in profitability, with a 1255.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zyllexa Formulations?
Unlock access to Zyllexa Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Shashikallada Shipping Consultancy LlpTarun Kodasseri is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Travancore : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2015 | State Bank Of Travancore | ₹1.00 M | Open |
How Many Employees Work at Zyllexa Formulations?
Unlock and access historical data on people associated with Zyllexa Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zyllexa Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zyllexa Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
